Matches in Wikidata for { <http://www.wikidata.org/entity/Q58868129> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q58868129 description "artículu científicu espublizáu en payares de 2014" @default.
- Q58868129 description "im November 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58868129 description "scientific article published on 27 November 2014" @default.
- Q58868129 description "wetenschappelijk artikel" @default.
- Q58868129 description "наукова стаття, опублікована в листопаді 2014" @default.
- Q58868129 name "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 name "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 type Item @default.
- Q58868129 label "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 label "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 prefLabel "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 prefLabel "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 P1433 Q58868129-B56FF568-84A9-4FD8-A993-5DF73F5367FA @default.
- Q58868129 P1476 Q58868129-49009997-BFDD-4D54-A30D-0DB23351FBD5 @default.
- Q58868129 P2093 Q58868129-2E741A40-A26D-4B81-B976-C6BA7FF8D656 @default.
- Q58868129 P2093 Q58868129-35D6FC66-0AF4-4D00-91F0-4F84C66C6A77 @default.
- Q58868129 P2093 Q58868129-9F00E7AC-CF5E-4340-BEF4-DC0539E8808B @default.
- Q58868129 P2093 Q58868129-AFAADB08-ED43-442B-9543-B7481EF029D0 @default.
- Q58868129 P2093 Q58868129-BACE635D-F77E-4035-A012-433AB1457F7D @default.
- Q58868129 P2093 Q58868129-D9CD002D-2987-4582-B321-E6E5C8BDF2BF @default.
- Q58868129 P2093 Q58868129-F3287965-FF87-474E-87B0-B740152CDC3E @default.
- Q58868129 P2860 Q58868129-37533852-29AE-4516-82C6-B8A670C51B8D @default.
- Q58868129 P2860 Q58868129-8BB025BC-AF18-4CBE-8E81-BC87D4C4BDFA @default.
- Q58868129 P2860 Q58868129-9BD85209-995E-40E2-80FC-A4896E21B105 @default.
- Q58868129 P304 Q58868129-0AA2FDF6-C6C1-455A-A5F9-88DEAE0194BE @default.
- Q58868129 P31 Q58868129-02CF2532-5ABF-4AA2-BBCC-A9896AA37FFB @default.
- Q58868129 P356 Q58868129-EE2368BB-467A-47B8-8F52-485BCBBE9C35 @default.
- Q58868129 P433 Q58868129-9C0015A1-2BB1-451C-B782-9A2204F042F8 @default.
- Q58868129 P478 Q58868129-2A6D0036-21E0-4989-8688-81F960C9FC56 @default.
- Q58868129 P50 Q58868129-5064FD19-B3B5-400A-AB22-40D9B5B95789 @default.
- Q58868129 P50 Q58868129-8B3BDC0E-3B1C-4BC2-AC40-51AE86D02611 @default.
- Q58868129 P50 Q58868129-F484DB86-C274-4267-8F55-AE80182628B2 @default.
- Q58868129 P577 Q58868129-970D1288-3F3F-4B98-9FFF-017AF1D2D580 @default.
- Q58868129 P698 Q58868129-DED043E0-8431-4501-895E-C7945B3A6BEC @default.
- Q58868129 P921 Q58868129-4E5EF6BC-717A-42EC-8014-582A7E6B9B65 @default.
- Q58868129 P921 Q58868129-5F7ED621-7CAF-4C29-A822-071565E1FBC0 @default.
- Q58868129 P921 Q58868129-6B2B0F2D-7EAE-4C35-B7DC-7358543701A5 @default.
- Q58868129 P921 Q58868129-D0884E0E-10A4-4045-A738-DD5F2EB6D553 @default.
- Q58868129 P356 DOM.12411 @default.
- Q58868129 P698 25387855 @default.
- Q58868129 P1433 Q5270109 @default.
- Q58868129 P1476 "Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy" @default.
- Q58868129 P2093 "A B King" @default.
- Q58868129 P2093 "A J Garber" @default.
- Q58868129 P2093 "C T Hansen" @default.
- Q58868129 P2093 "J Rosenstock" @default.
- Q58868129 P2093 "M Niemeyer" @default.
- Q58868129 P2093 "P Hollander" @default.
- Q58868129 P2093 "S Sreenan" @default.
- Q58868129 P2860 Q34269834 @default.
- Q58868129 P2860 Q42240405 @default.
- Q58868129 P2860 Q49174475 @default.
- Q58868129 P304 "202-206" @default.
- Q58868129 P31 Q13442814 @default.
- Q58868129 P356 "10.1111/DOM.12411" @default.
- Q58868129 P433 "2" @default.
- Q58868129 P478 "17" @default.
- Q58868129 P50 Q41467287 @default.
- Q58868129 P50 Q46124994 @default.
- Q58868129 P50 Q59207943 @default.
- Q58868129 P577 "2014-11-27T00:00:00Z" @default.
- Q58868129 P698 "25387855" @default.
- Q58868129 P921 Q2002370 @default.
- Q58868129 P921 Q3025883 @default.
- Q58868129 P921 Q417317 @default.
- Q58868129 P921 Q7240673 @default.